Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 78.47

-1.5%

Jan 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2208)	8/20/1998 10:27:00 PM
From: marc ultra	of 4676

mz,re:Some investor think that this immune response stimulation is main reasons for Isis drug efficiency in CMV (and Crohn's),> Could be true in CMV but would be hard to explain in Crohn's since you are trying to get an immunodepressant effect and immune stimulation likely to make it worse Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next